1 week ago - Some sites are on beta cells in the pancreas and on neurons in the brain. GLP-1 receptor activation slows gastric emptying, inhibits the release of glucagon, and stimulates insulin production, thereby improving glucose homeostasis in people with type 2 diabetes.
- The higher the dose of the GLP-1 agonist, the more extreme the effects. If you have Type 2 diabetes, the medications help manage your blood sugar by triggering your pancreas to release more insulin.
- GLP-1R, a core member of the GPCR ... therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases.5,6,7 GLP-1 is a peptide produced ...
- Liraglutide/insulin-degludec has obtained FDA approval, affirming their effectiveness and safety in diabetes management.[12][13] Because of safety concerns, research on another agent, taspoglutide, has been halted in phase III trials.[14] Recently, Orforglipron, a nonpeptide oral GLP-1 receptor ...
- The aim of this review is to summarize available preclinical and clinical data on the beneficial effects of GLP-1 receptor agonists on atherosclerosis and cardiovascular disease which has the potential to substantially broaden the scope of their clinical applications. ... Summary of cardiovascular effects of GLP-1 receptor agonists.
You should only be given a prescription for a GLP-1 agonist following an assessment by your healthcare team to make sure that you meet the criteria and that youll benefit from it. This should be an individual assessment that includes how this medication will fit into your current treatment plan and considers any diet or activity programme that you are following, as well as the risk of side effects, the dose youll need, and your personal choices.
- Beyond the impressive effects of ... that GLP-1 receptor agonists reduce cardiovascular risk and slow progression to renal failure in persons at high risk and those with type 2 diabetes....
:max_bytes(150000):strip_icc()/HDC-GettyImages-2195485788-299e147644524b339a084114355dff83.jpg "Image result for GLP-1 agonist treatment for anti-phospholipid syndrome and diabetes")
